Skip to main content

Miguel García Gabilondo

Institutions of which they are part

Research technician
Neurovascular Diseases
Vall Hebron Institut de Recerca

Miguel García Gabilondo

Institutions of which they are part

Research technician
Neurovascular Diseases
Vall Hebron Institut de Recerca

Projects

Administració endovascular de nanomaterials terapèutics per la recuperació de l’ictus.

IP: Anna Rosell Novel
Collaborators: Anna Penalba Morenilla, Kerrie Adrián Campbell, Miguel García Gabilondo
Funding agency: Fundació La Marató de TV3
Funding: 173750
Reference: MARATO/205/C/2023
Duration: 22/04/2024 - 21/04/2027

Malalties neurovasculars

IP: Anna Rosell Novel
Collaborators: Mercedes Arrue Gonzalo, Joan Montaner Villalonga, Marcel Lamana Vallverdu, Anna Penalba Morenilla, Anna Bonaterra Pastra, Maria Mar Hernandez Guillamon, Olga Maisterra Santos, Maria Pilar Delgado Martínez, Antonio Palasi Franco, Jesús Pizarro Gonzálvez, Paula Garcia Rodriguez, Miguel García Gabilondo, Nicolas Garcia Rodriguez
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 40000
Reference: 2021 SGR 00656
Duration: 01/01/2022 - 30/06/2025

Tratamientos endovasculares de neuroprotección y neuroreparación en la recuperación del ictus.

IP: Anna Rosell Novel
Collaborators: Anna Penalba Morenilla, Paula Garcia Rodriguez, Miguel García Gabilondo
Funding agency: Instituto de Salud Carlos III
Funding: 141570
Reference: PI22/01055
Duration: 01/01/2023 - 31/12/2025

Endothelial progenitor cells labelled with superparamagnetic iron oxide micro and nanoparticles in cerebrovascular disorders, process for their preparation and uses thereof.

IP: Anna Rosell Novel
Collaborators: Miguel García Gabilondo
Funding agency: Generalitat de Catalunya - Departament de Salut
Funding: 71734.81
Reference: SLT017/20/000197
Duration: 01/07/2021 - 31/12/2023

Related news

The TOUCH MSCA-COFUND doctoral training programme, led by UAB and focusing on the field of mental health, has opened its first call for applications, offering 13 doctoral positions.

The Cardiovascular Diseases and Neurovascular Diseases groups at VHIR will investigate new therapeutic strategies for heart failure, nanomedicine in stroke and the prevention of cardiovascular toxicity in the case of oncological treatments.

La recerca és fonamental per contrarestar els efectes de la pol·lució, que segons l’AEMPS, va ser la causa de més de 300.000 morts prematures a la UE el 2020.

Related professionals

Margarita Navarro Pérez

Margarita Navarro Pérez

Administration and Management
Clinical Neuroimmunology
Read more
Laura Collado Gómez

Laura Collado Gómez

Tècnic/a Grau Superior
National Unit
Competitive Research Directorate
Read more
Joaquim Vives Armengol

Joaquim Vives Armengol

Main researcher
Musculoskeletal Tissue Engineering
Read more
Natalia Pilar Costa Allue

Natalia Pilar Costa Allue

Research technician
Shock, Organ Dysfunction and Resuscitation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.